DICEL DM
-
chlorpheniramine maleate,
dextromethorphan hydrobromide and
pseudoephedrine hydrochloride tablet, chewable
Centrix Pharmaceutical
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
Active ingredients
(in each chewable)
Chlorpheniramine Maleate 2mg
Dextromethorphan Hydrobromide 10mg
Pseudoephedrine Hydrochloride 30mg
Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for two weeks after stopping the MAOI drug. If you do no know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have
When using this product
Stop use and ask a doctor if
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Uses temporarily relieves these symptoms due to a cold, hay fever or other upper respiratory allergies
Inactive ingredients Acelylated Monoglycerine, Ammonium Glycyrrhizate, Cellulose Acetate, Croscarmellose Sodium, Ethylcellulose, Eudragit E acrylic polymer, FD and C Blue #1 Lake, Flavors, Hydroxypropylmethylcellulose, Hydroxypropylcellulose, Malic Acid, Meltodextrin, Microcrystalline Cellulose, Polyethylene Glycol, Sodium Lauryl Sulfate, Soy Lecithin, Sucralose, Sugar, Vegetable Oil
Directions
adults and children 12 years of age and over | 2 chewables every 4 to 6 hours |
children 6 to under 12 years of age | one chewable every 4 to 6 hours |
children under 6 years of age | consult a doctor |
DICEL
DM
chlorpheniramine/dextromethorphan/pseudoephedrine tablet, chewable |
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
OTC monograph final | part341 | 09/30/2010 | 05/25/2012 |
Labeler - Centrix Pharmaceutical (185405367) |
Registrant - Elge Inc (610655136) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Elge Inc | 610655136 | manufacture |
Revised: 05/2012 Centrix Pharmaceutical